~ Buy the VEREGEN (sinecatechins) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR VEREGEN

All Clinical Trials for veregen

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01082302 ↗	Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage	Completed	Charité Research Organisation GmbH	Phase 4	2010-01-01	This open, monocentric study is designed to investigate plasma concentrations of certain catechins after topical application of Veregen 15% ointment to genital or perianal warts in comparison to catechin plasma concentrations after oral intake of a defined dose of green tea beverage. The study is intended to demonstrate that topical administration of Veregen 15% induces catechin plasma concentrations lower or equivalent to those that can be reached with normal consumption of green tea.
NCT01082302 ↗	Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage	Completed	Charité Research Organization GmbH	Phase 4	2010-01-01	This open, monocentric study is designed to investigate plasma concentrations of certain catechins after topical application of Veregen 15% ointment to genital or perianal warts in comparison to catechin plasma concentrations after oral intake of a defined dose of green tea beverage. The study is intended to demonstrate that topical administration of Veregen 15% induces catechin plasma concentrations lower or equivalent to those that can be reached with normal consumption of green tea.
NCT01082302 ↗	Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage	Completed	MediGene	Phase 4	2010-01-01	This open, monocentric study is designed to investigate plasma concentrations of certain catechins after topical application of Veregen 15% ointment to genital or perianal warts in comparison to catechin plasma concentrations after oral intake of a defined dose of green tea beverage. The study is intended to demonstrate that topical administration of Veregen 15% induces catechin plasma concentrations lower or equivalent to those that can be reached with normal consumption of green tea.

Clinical Trial Conditions for veregen

Condition Name

Condition Name for veregen
Intervention	Trials
Genito-Pelvic Pain/Penetration Disorder	1
Lamellar Ichthyosis	1
Perianal Warts	1

Condition MeSH

Condition MeSH for veregen
Intervention	Trials
Warts	4
Condylomata Acuminata	3
Pelvic Pain	1

Clinical Trial Locations for veregen

Trials by Country

Trials by Country for veregen
Location	Trials
United States	27
Germany	2
France	1
Guam	1
Netherlands	1

Trials by US State

Trials by US State for veregen
Location	Trials
Texas	2
New York	2
Missouri	1
Minnesota	1
Michigan	1

Clinical Trial Progress for veregen

Clinical Trial Phase

Clinical Trial Phase for veregen
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	1
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for veregen
Clinical Trial Phase	Trials
Completed	5
Unknown status	1
Recruiting	1

Clinical Trial Sponsors for veregen

Sponsor Name

Sponsor Name for veregen
Sponsor	Trials
MediGene	2
Will-Pharma	1
Maastricht University Medical Center	1

Sponsor Type

Sponsor Type for veregen
Sponsor	Trials
Other	8
Industry	5
NIH	1